| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 11 |
| 1 | ASPIRIN | 10 |
| 2 | ASPIRIN 325 MG | 9 |
| 3 | ASPIRIN 81 MG | 9 |
| 4 | ERGOCALCIFEROL | 9 |
| 5 | ADALIMUMAB | 6 |
| 6 | APIXABAN | 6 |
| 7 | RIVAROXABAN | 6 |
| 8 | ENZALUTAMIDE | 5 |
| 9 | GABAPENTIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 1 | VALERIAN | 1 | 0.0014 |
| 2 | GARADACIMAB | 1 | 0.0013 |
| 3 | NATEGLINIDE | 1 | 0.0007 |
| 4 | ERGOCALCIFEROL | 9 | 0.0003 |
| 5 | BICALUTAMIDE | 4 | 0.0003 |
| 6 | BAYER ASPIRIN EXTRA STRENGTH | 1 | 0.0003 |
| 7 | ACITRETIN | 1 | 0.0002 |
| 8 | TIMOLOL | 2 | 0.0002 |
| 9 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 12 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 3 | Androgen Receptor Inhibitor [EPC] | 9 |
| 4 | Provitamin D2 Compound [EPC] | 9 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 6 | Calcium [EPC] | 4 |
| 7 | Osmotic Laxative [EPC] | 4 |
| 8 | Thiazide Diuretic [EPC] | 4 |
| 9 | GLP-1 Receptor Agonist [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 1 | Androgen Receptor Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 3 | 0.0001 |
| 3 | Glinide [EPC] | 1 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Cholinergic Muscarinic Antagonist [EPC] | 2 | 0.0001 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Factor Xa Inhibitor [EPC] | 12 | 0.0000 |
| 8 | Bile Acid [EPC] | 1 | 0.0000 |
| 9 | beta3-Adrenergic Agonist [EPC] | 2 | 0.0000 |